Myomo (MYO) Operating Expenses (2016 - 2025)
Myomo's (MYO) quarterly Operating Expenses came in at $10.0 million in Q3 2025, up 26.02% on a YoY basis from $7.9 million in Q3 2024, and down 6.42% quarter-over-quarter from $10.6 million in Q2 2025.
Analysis
Myomo (MYO) Operating Expenses (2016 - 2025) Analysis & Trends
Myomo (MYO) has reported Operating Expenses for 10 consecutive years, with $10.0 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Operating Expenses rose 26.02% year-over-year to $10.0 million; the trailing twelve-month figure through Sep 2025 stood at $39.6 million (up 51.87% YoY), and the FY2024 full-year result was $29.4 million, up 37.26% from the prior year.
- Operating Expenses declined to $10.0 million in Q3 2025 per MYO's latest filing, from $10.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $10.6 million in Q2 2025 and bottomed at $4.6 million in Q1 2021.
- Historically, Operating Expenses has averaged $6.5 million across 5 years, with a median of $5.5 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses dropped 16.66% in 2022, then surged 65.24% in 2025.
- Over 5 years, Operating Expenses stood at $5.8 million in 2021, then decreased by 16.66% to $4.9 million in 2022, then advanced by 14.02% to $5.5 million in 2023, then soared by 59.99% to $8.9 million in 2024, then increased by 12.41% to $10.0 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $10.0 million, $10.6 million, and $10.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 10.90 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 988.50 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 3.97 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 2.84 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 2.67 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 846.40 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -1.63 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 511.70 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 398.30 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 9.96 Mn |
| Jun 30, 2025 | 10.64 Mn |
| Mar 31, 2025 | 10.13 Mn |
| Dec 31, 2024 | 8.86 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 6.44 Mn |
| Mar 31, 2024 | 6.19 Mn |
| Dec 31, 2023 | 5.54 Mn |
| Sep 30, 2023 | 5.51 Mn |
| Jun 30, 2023 | 5.38 Mn |
| Mar 31, 2023 | 4.98 Mn |
| Dec 31, 2022 | 4.86 Mn |
| Sep 30, 2022 | 5.46 Mn |
| Jun 30, 2022 | 5.30 Mn |
| Mar 31, 2022 | 5.32 Mn |
| Dec 31, 2021 | 5.83 Mn |
| Sep 30, 2021 | 5.30 Mn |
| Jun 30, 2021 | 4.80 Mn |
| Mar 31, 2021 | 4.65 Mn |
| Dec 31, 2020 | 4.47 Mn |